Google Alert - pharmaceutical news

News 9 new results for pharmaceutical news

Stellar Pharmaceuticals Shows Strong Third Quarter Revenue Growth to $3.2 ... Stockhouse 13, 2012) - Stellar Pharmaceuticals Inc. (OTCQB:SLXCF)(OTCBB:SLXCF)(PINKSHEETS:SLXCF) ("Stellar" or "the Company"), a specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare ... See all stories on this topic »

Edison Pharmaceuticals Announces Initiation of EPI-743 Phase 2B Leigh ... Sacramento Bee MOUNTAIN VIEW, Calif., Nov. 13, 2012 -- /PRNewswire/ -- Edison Pharmaceuticals today announced the initiation of a phase 2B study entitled, "A Phase 2B Randomized, Placebo-Controlled, Double-Blind Clinical Trial of EPI-743 in Children with Leigh ... See all stories on this topic »

TEKMIRA PHARMACEUTICALS CORPORATION : Tekmira Provides Corporate ... 4-traders On November 12, 2012, Tekmira announced that it entered into a settlement agreement with Alnylam Pharmaceuticals, Inc. that resolves all litigation between the companies, and signed a new licensing agreement that restructures the relationship and ... See all stories on this topic »

Savara Pharmaceuticals' AeroVanc Granted U.S. Orphan Drug Designation for ... Sacramento Bee 13, 2012 -- /PRNewswire/ -- Savara Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug status to AeroVanc™ (vancomycin hydrochloride inhalation powder) for the treatment of pulmonary ... See all stories on this topic »

Tonix Pharmaceuticals Presents Research Findings at the 2012 American ... Equities.com NEW YORK, NY -- (Marketwire) -- 11/13/12 -- Tonix Pharmaceuticals Holding Corp. (OTCQB: TNXP) ("TONIX" or "the Company"), a specialty pharmaceutical company developing novel treatments for challenging disorders of the central nervous system ... See all stories on this topic »

Most Read Pharmaceutical and Health Condition News - October '12 Sacramento Bee AUSTIN, Texas, Nov. 13, 2012 -- /PRNewswire/ -- dailyRx, Inc., a leading digital news publisher, announced today the top five health conditions and medications viewed on the dailyRx News Network during October 2012. dailyRx News is syndicated to ... See all stories on this topic »

Consider Ironwood Pharmaceuticals Amidst Strong Insider Support Seeking Alpha Ironwood Pharmaceuticals announced on October 23 that the company came to an agreement with pharmaceutical giant AstraZeneca (AZN) in order to co-develop and co-commercialize linaclotide in China. AstraZeneca stated that it will made an upfront ... See all stories on this topic »

Buy Sun Pharma; target of Rs 800: Emkay Moneycontrol.com Emkay Global Financial Services is bullish on Sun Pharmaceutical Industries and has recommended buy rating on the stock with a target of Rs 800 in its November 9, 2012 research report. Source: Moneycontrol.com ... See all stories on this topic » Moneycontrol.com

Adderall. How a pharmaceutical drug became a de rigeur study drug at most ... scallywagandvagabond The following essay comes courtesy of Valerie Harris who decided to examine the culture of 'study drugs' as they are euphemistically known on college campuses, the most commonly and obsequious drug of choice these days being adderall, ... See all stories on this topic » scallywagandvagabond

---

Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.

Delete this alert.
Create another alert.
Manage your alerts.